| Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis MP Raitanen, R Aine, E Rintala, J Kallio, P Rajala, H Juusela, ... European urology 41 (3), 284-289, 2002 | 292 | 2002 |
| Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study T Liukkonen, P Rajala, M Raitanen, E Rintala, E Kaasinen, P Lipponen European urology 36 (5), 393-400, 1999 | 127 | 1999 |
| Perioperative single dose instillation of epirubicin or interferon-α after transurethral resection for the prophylaxis of primary superficial bladder cancer recurrence: a … P Rajala, E Kaasinen, M Raitanen, T Liukkonen, E Rintala, ... The Journal of urology 168 (3), 981-985, 2002 | 119 | 2002 |
| The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies MP Raitanen, FinnBladder Group World journal of urology 26, 45-50, 2008 | 106 | 2008 |
| Complement factor H as a marker for detection of bladder cancer ZZ Cheng, MJ Corey, M Pärepalo, S Majno, J Hellwage, PF Zipfel, ... Clinical chemistry 51 (5), 856-863, 2005 | 86 | 2005 |
| Immunonutrition in elective gastrointestinal surgery patients H Helminen, M Raitanen, J Kellosalo Scandinavian journal of surgery 96 (1), 46-50, 2007 | 80 | 2007 |
| Charge-dependent targeting: results in six tumor cell lines M Márquez, S Nilsson, L Lennartsson, Z Liu, T Tammela, M Raitanen, ... Anticancer research 24 (3A), 1347-1352, 2004 | 79 | 2004 |
| Transurethral resection with perioperative instillation of interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective … P Rajala, T Liukkonen, M Raitanen, E Rintala, E Kaasinen, M Helle, ... The Journal of urology 161 (4), 1133-1136, 1999 | 78 | 1999 |
| Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder MP Raitanen, P Nieminen, TLJ Tammela British journal of urology 76 (4), 470-474, 1995 | 67 | 1995 |
| Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer T Liukkonen, P Lipponen, M Raitanen, E Kaasinen, M Ala-Opas, P Rajala, ... Urological research 28, 285-292, 2000 | 60 | 2000 |
| Analysis of false-positive BTA STAT test results in patients followed up for bladder cancer MP Raitanen, E Kaasinen, O Lukkarinen, R Kauppinen, J Viitanen, ... Urology 57 (4), 680-684, 2001 | 58 | 2001 |
| Human complement factor H related protein test for monitoring bladder cancer MP RAITANEN, T MARTTILA, M NURMI, M ALA-OPAS, P Nieminen, ... The Journal of urology 165 (2), 374-377, 2001 | 58 | 2001 |
| Treatment of postoperative male urinary incontinence using transurethral macroplastique injections T Kylmälä, H Tainio, M Raitanen, TLJ Tammela Journal of endourology 17 (2), 113-115, 2003 | 53 | 2003 |
| Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer MP Raitanen, T Marttila, E Kaasinen, E Rintala, R Aine, TLJ TAMMELA, ... The Journal of urology 163 (6), 1689-1692, 2000 | 52 | 2000 |
| p53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer MP Raitanen, TLJ Tammela, M Kallioinen, J Isola The Journal of urology 157 (4), 1250-1253, 1997 | 47 | 1997 |
| Intravesical bacillus Calmette-Guérin versus combination of Epirubicin and interferon-α2a in reducing recurrence of non–muscle-invasive bladder carcinoma: FinnBladder-6 study T Marttila, R Järvinen, T Liukkonen, E Rintala, P Boström, M Seppänen, ... European urology 70 (2), 341-347, 2016 | 39 | 2016 |
| A controlled study of intravesical epirubicin with or without alpha2b‐interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder MP RAITANEN, O Lukkarinen, Finnish Multicentre Study Group British journal of urology 76 (6), 697-701, 1995 | 38 | 1995 |
| Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer. MP Raitanen, M Leppilahti, K Tuhkanen, T Forssel, P Nylund, T Tammela Annales chirurgiae et gynaecologiae 90 (4), 261-265, 2001 | 36 | 2001 |
| Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test MP Raitanen, P Hellström, T Marttila, H Korhonen, M Talja, J Ervasti, ... European urology 40 (4), 422-426, 2001 | 28 | 2001 |
| Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance PU Malmström, M Grabe, ES Haug, P Hellström, GG Hermann, ... Scandinavian journal of urology and nephrology 46 (2), 108-116, 2012 | 22 | 2012 |
